Company intelligence / Profile preview

Organix

Woburn, Massachusetts, United Statesorganix.com ↗

Ownership: Private
Employees: ~50
Development stage: Other

Overview

Organix is a leading US-based contract research organization specializing in organic and medicinal chemistry. The company provides custom synthesis, analytical services, drug delivery solutions (notably lipids for LNPs), polymer chemistry expertise, and process development to support pharmaceutical R&D from early discovery through preclinical stages. It does not develop its own clinical pipeline but enables client programs across the industry.

Therapeutic areas: Other
Modalities: Small moleculeOligonucleotideLipid nanoparticle delivery therapyPolymer
Industry: Drug Discovery Services

Partnerships

Works with over 120 clients including most multinational pharmaceutical companies and numerous biopharma firms. Now part of Symeres Group.

Beyond the preview

Go deeper on Organix.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Organix.

Explore the full profile